Dartmouth Cystic Fibrosis Research Center (DartCF) is one of seven national CF research and translation centers funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). DartCF, directed by Dean Madden, was launched in 2018. It provides core research facilities, access to clinical samples, biostatistical support, and pilot project funding for groups working on the GI and systemic aspects of CF disease. DartCF works closely with the CF Foundation Research Development Program headed by Bruce Stanton, with the CF and M2P2 training grants headed by George O'Toole and Deb Hogan, and with Dartmouth's CF Cluster faculty, Jim Bliska and Ben Ross. These colleagues also lead key components of DartCF, together with Ali Ashare, Tim Gardner, and Todd MacKenzie. More than 30 faculty members participate campus wide.
The Institute for Biomolecular Target (bioMT) is an NIH-funded Center of Biomedical Research Excellence that supports research projects, pilot projects, and core facilities in biochemistry and cell biology across Geisel, Thayer, and Arts & Sciences departments. Our goal is to couple fundamental and translational approaches, creating an interdisciplinary center that supports research at the frontiers of health and disease.
The Dartmouth Cancer Center is a National Cancer Institute designated comprehensive cancer center that fosters collaborative, interdisciplinary research into the biology, causes, prevention, and treatment of cancer. Throughout its history, Dartmouth Cancer Center scientists have made significant contributions to knowledge in these areas. The scientific investigations are organized into six Research Programs: Cancer Control, Cancer Epidemiology, Cancer Imaging and Radiobiology, Cancer Mechanisms, Immunology and Cancer Immunotherapy, and Molecular Therapeutics.